Today's After-Hours Stock Movers

Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) 63% LOWER; announced that the Phase 3 PolarisDMD trial of edasalonexent in Duchenne muscular dystrophy (DMD) did not meet the primary endpoint, which was a change from baseline in the North Star Ambulatory Assessment (NSAA) over one year of edasalonexent compared to placebo. The secondary endpoint timed function tests (time to stand, 10-meter walk/run and 4-stair climb) also did not show statistically significant improvements. Edasalonexent was observed to be generally safe and well-tolerated in this trial. Catabasis is stopping activities related to the development of edasalonexent including the ongoing GalaxyDMD open-label extension trial. The Company plans to work with external advisors to explore and evaluate strategic options going forward.

K12, Inc. (NYSE: LRN) 9.2% HIGHER; reported Q1 EPS of $0.30, $0.61 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $371 million versus the consensus estimate of $362.52 million. K12, Inc. sees Q2 2021 revenue of $358-366 million, versus the consensus of $366 million. K12, Inc. sees FY2021 revenue of $1.445-1.47 billion, versus the consensus of $1.44 billion.

Varonis Systems (NASDAQ: VRNS) 9% HIGHER; reported Q3 EPS of $0.06, $0.19 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $76.8 million versus the consensus estimate of $70.17 million. Varonis Systems sees Q4 2020 EPS of $0.10-$0.13, versus the consensus of ($0.02). Varonis Systems sees Q4 2020 revenue of $82-85 million, versus the consensus of $79.76 million.

DexCom, Inc. (NASDAQ: DXCM) 7.4% LOWER; Dexcom achieved half a billion dollars in revenue in the third quarter, with revenues of $500.9 million, representing 26% growth over the third quarter of 2019. (*Consensus sees Q3 revenue of $476.75 million)

American International Group Inc (NYSE: AIG) 6.6% HIGHER; plans to separate its life and retirement business unit from the parent company.

Chegg (NYSE: CHGG) 5.4% LOWER; reported Q3 EPS of $0.17, $0.07 better than the analyst estimate of $0.10. Revenue for the quarter came in at $154 million versus the consensus estimate of $143.68 million. Chegg sees Q4 2020 revenue of $188-190 million, versus the consensus of $183.2 million. Chegg sees FY2020 revenue of $626-628 million, versus the consensus of $611.6 million.

Las Vegas Sands (NYSE: LVS) 4.7% HIGHER; is exploring the sale of its flagship casinos in Las Vegas, according to Bloomberg, citing people familiar with the matter.

F5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $2.43, $0.06 better than the analyst estimate of $2.37. Revenue for the quarter came in at $615 million versus the consensus estimate of $606.29 million. F5 Networks sees Q1 2021 EPS of $2.26-$2.38, versus the consensus of $2.28. F5 Networks sees Q1 2021 revenue of $595-615 million, versus the consensus of $592.8 million.

Mirati Therapeutics, Inc. (Nasdaq: MRTX) 4.4% LOWER; intends to offer and sell in an underwritten public offering $700.0 million of shares of its common stock and a selling stockholder intends to offer 375,000 shares in the offering.

Harmonic (NASDAQ: HLIT) 4.4% LOWER; reported Q3 EPS of $0.03, $0.08 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $94.9 million versus the consensus estimate of $82.05 million. Harmonic sees Q4 2020 EPS of $0.10-$0.18, versus the consensus of $0.17. Harmonic sees Q4 2020 revenue of $120-130 million, versus the consensus of $130.98 million. Harmonic sees FY2020 EPS of ($0.03)-$0.04, versus the consensus of ($0.04). Harmonic sees FY2020 revenue of $367.5-377.5 million, versus the consensus of $365.44 million.

dMY Technology Group, Inc. II (NYSE: DMYD) 3.7% HIGHER; Genius Sport Said in Talks to Go Public Via SPAC, dMY Technology Group, Inc. II (NYSE: DMYD) - Bloomberg

NXP Semiconductors (NASDAQ: NXPI) 3.5% HIGHER; reported Q3 EPS of ($0.08), which does not compare to the analyst estimate of $1.53. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.23 billion. NXP Semiconductors sees Q4 2020 revenue of $2.375-2.525 billion, versus the consensus of $2.27 billion.

Flexsteel (NASDAQ: FLXS) 3.5% HIGHER; reported Q1 EPS of $0.80, versus $0.00 reported last year. Revenue for the quarter came in at $105.2 million, versus $100.3 million reported last year.

Moelis & Company (NYSE: MC) 2.8% HIGHER; reported Q3 EPS of $0.54, $0.51 better than the analyst estimate of $0.03. Revenue for the quarter came in at $207.6 million versus the consensus estimate of $145.08 million.

Twilio (NYSE: TWLO) 1.6% LOWER; reported Q3 EPS of $0.04, $0.07 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $448 million versus the consensus estimate of $409.79 million. Twilio sees Q4 2020 EPS of ($0.11)-($0.08), versus the consensus of $0.01. Twilio sees Q4 2020 revenue of $450-455 million, versus the consensus of $436.84 million.